Ovarian Cancer News & Features
-
IVF Won't Raise Ovarian Cancer Risk: Study
Previous studies suggested that women who used this assisted reproductive technologies (ART) such as IVF to get pregnant may be at risk for ovarian cancer and non-malignant borderline tumors
-
Advanced Ovarian Cancer: Survival & NAC Use Continue to Increase
Survival of patients with advanced ovarian cancer continues to increase, despite concerns that increased use of neoadjuvant chemotherapy (NAC) could have a negative impact on outcomes.
-
Meet Kenni, a ‘Little Spitfire’ Who’s Cancer-Free
At only 2 years of age, McKenna Xydias is a cancer survivor.
-
Obamacare May Have Aided Fight Vs. Ovarian Cancer
or the study, the investigators analyzed data from the U.S. National Cancer Database. They compared nearly 36,000 women who were diagnosed and treated between 2004 and 2009, with more than 37,000 women diagnosed and treated between 2011 and 2014.
-
Study: The Pill May Protect Against Ovarian Cancer
After adjusting for such factors as age and whether women had ever given birth, any use of birth control pills was associated with a 46% lower risk of death within a year of an ovarian cancer diagnosis, the study found.
-
U.S. Agencies Investigating Asbestos in Baby Powder
Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.
-
Low-Dose Aspirin May Cut Ovarian Cancer Risk
Researchers say that women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23 percent lower risk of developing ovarian cancer than those who did not regularly take aspirin.
-
Low-Dose Aspirin May Help Against Ovarian Cancer
One low-dose aspirin -- the type many older women already take to help their hearts -- was tied to a 10 percent reduction in developing ovarian cancer and as much as a 30 percent improvement in survival for ovarian cancer patients, two new studies have found.
-
Jury Awards $4.62 Billion in Baby Powder Lawsuit
A jury says Johnson & Johnson must pay $4.62 billion to 22 women who allege they developed ovarian cancer after using the company's Baby Powder and Shower to Shower brand talcum powder as part of their daily feminine hygiene routine.
-
Early Success in Artificial Ovary Research
However, there is a slight risk that the ovarian tissue may contain cancer cells, putting a woman at risk for the return of her cancer.
-
Researchers Making Progress Against Ovarian Cancer
One study found that a new targeted "immunotherapy" to treat ovarian cancer that has come back looked promising in a small, early trial.
-
Could a Pap Test Spot More Than Cervical Cancer?
The researchers behind the new study developed a testing regimen called PapSEEK to see if additional samples collected during a pelvic exam could be used to detect endometrial or ovarian cancer.
-
Routine Ovarian Cancer Screenings Aren't Helping
Screening not only didn’t prevent any deaths, it also led to harm, the panel said.
-
Pill Cuts Ovarian Cancer Risk, Even for Smokers
According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well.
-
Talcum Powder/Ovarian Cancer Lawsuit Award Tossed
Award in Missouri case set aside upon appeal. Does not affect larger California award in similar suit.
-
Verdict was fourth against Johnson & Johnson
Verdict was fourth against Johnson & Johnson
-
Ovarian Cancer Drug Given Fast-Track Approval
Ovarian Cancer Drug Given Fast-Track Approval
-
Does Baby Powder Cause Ovarian Cancer?
Leading cancer and women's health groups say probably not
-
Woman Gets $70M in Baby Powder/Ovarian Cancer Suit
Woman Gets $70M in Baby Powder/Ovarian Cancer Suit
-
FDA Warns Ovarian Cancer Tests Not Reliable
May delay preventive therapies for high-risk women, spur unnecessary procedures in some without cancer
-
Know Your Ovarian Cancer Risk -- and the Symptoms
Because early signs are often easy to ignore, 140,000 women worldwide die of the disease every year
-
Is the Pill Tied to Fewer Ovarian Cancer Deaths?
Rates down 16 percent in U.S., 8 percent in Canada, and 10 percent in Europe over a decade: study
-
Exercise May Help Thwart Ovarian Cancer
Chronic inactivity linked to greater risk for the disease in study
-
This Helps Some With Advanced Ovarian Cancer
Study found using both abdomen drip and IV delayed progression of disease
-
Ovarian Cancer Patients and Life-Extending Surgery
Advanced age, disease were predictors for receiving only chemo, radiation or nothing at all
Pagination